MedPath

Effects of denosumab for bone resorption in the femur after total hip arthroplasty

Not Applicable
Recruiting
Conditions
patients treated with primary total hip arthroplasty
Registration Number
JPRN-UMIN000028169
Lead Sponsor
Yokohama City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Severe renal failure (CCr:less than 30mL/min) (2) Hypercalcemea or hypocalcemia (3) Past history of femoral osteotomy (4) Systemic bone disease (5) Patients, who are considered to be inappropriate for this study by doctors.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath